Teva Pharmaceutical Industries Shares Outstanding 2010-2024 | TEVA

Teva Pharmaceutical Industries shares outstanding for the quarter ending December 31, 2024 were 1.131B, a 1.07% increase year-over-year.

  • Teva Pharmaceutical Industries 2024 shares outstanding were 1.131B, a 1.07% increase from 2023.
  • Teva Pharmaceutical Industries 2023 shares outstanding were 1.119B, a 0.81% increase from 2022.
  • Teva Pharmaceutical Industries 2022 shares outstanding were 1.11B, a 0.27% increase from 2021.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Teva Pharmaceutical Industries Shares Outstanding 2010-2024 | TEVA

  • Teva Pharmaceutical Industries 2024 shares outstanding were 1.131B, a 1.07% increase from 2023.
  • Teva Pharmaceutical Industries 2023 shares outstanding were 1.119B, a 0.81% increase from 2022.
  • Teva Pharmaceutical Industries 2022 shares outstanding were 1.11B, a 0.27% increase from 2021.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$11.2B
BridgeBio Pharma (BBIO)$6.9B
Bausch Health Cos (BHC)$2.4B
Supernus Pharmaceuticals (SUPN)$1.9B
Amphastar Pharmaceuticals (AMPH)$1.5B
Personalis (PSNL)$412M
Taysha Gene Therapies (TSHA)$336M
Assembly Biosciences (ASMB)$81M
Sol-Gel Technologies (SLGL)$16M
Evoke Pharma (EVOK)$8M
Teligent (TLGT)$0M